p-Xylylene-a,a'-bispyridinium dibromide, 95%, 100mg

Ethyl 3-(3-thienyl)-3-oxopropionate, 95.0%, 250mg

Methyl 3-(2-Pyridyl)propanoate, 95.0%, 250mg

1-(3-Methoxyphenyl)-2-methylpropan-2-amine, 95%, 1g

Dietilcetona, mínimo 99 %, para síntesis, 500 ml, envase de vidrio

5-Bromo-2-fluoro-N-methyl-benzenesulfonamide, 95%+, 100mg

Methyl 4-oxo-1,2,3,4-tetrahydronaphthalene-1-carboxylate, 95.0%, 250mg

N-(pyrrolidin-3-yl)pyridazin-3-amine dihydrochloride, 95.0%, 250mg

ethyl 2-azido-3-[(tert-butoxycarbonyl)amino]-3-(3-methoxyphenyl)propanoate, 50mg

2-Bromopyrimidine, 97.0%, 25g

2-[2-(2-methyl-1H-imidazol-1-yl)ethyl]piperidine dihydrochloride hydrate, 95.0%, 5g

3-Methyl-1-(pyridin-3-ylmethyl)-1H-pyrazole-5-carboxylic acid, 1g

4-(4-Hydroxy-4-methylpentyl)cyclohex-3-enecarbaldehyde, 95.0%, 25g